Revlimid (lenalidomide) is a brand-name oral capsule prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

The FDA warned that doctors should be on the alert for symptoms and discontinue the drug if a rash appears. According to the company, 60,000 patients have been treated with Revlimid since it was ...

REVLIMID interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID must be discontinued for angioedema, Grade 4 rash, exfoliative or bullous rash, or if SJS or TEN is ...

Revlimid® had annual sales of $2.3 billion as of December 2021, according to IQVIA data. What are lenalidomide capsules? ... have had a serious skin rash with thalidomide treatment.

REVLIMID ® (lenalidomide) interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID ® (lenalidomide) must be discontinued for angioedema, Grade 4 rash, exfoliative ...

Results showed that Revlimid in combination with rituximab was associated with a statistically significant improvement in median PFS of 39.4 months compared with a median PFS with rituximab plus ...

REVLIMID ® (lenalidomide) interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID ® (lenalidomide) must be discontinued for angioedema, Grade 4 rash, exfoliative ...

Bristol-Myers Squibb Company today announced that the European Commission has approved a new indication for Revlimid, in combination with rituximab, for the treatment of adult patients with ...